Colchicine treatment in COVID-19: the remaining unsolved question

Lancet Respir Med. 2021 Dec;9(12):1351-1353. doi: 10.1016/S2213-2600(21)00462-8. Epub 2021 Oct 21.

Authors

Adriana Rojas-Villarraga¹, Rafael Parra-Medina², Arley Gómez-López³

Affiliations

¹ Research Institute, Fundación Universitaria de Ciencias de la Salud, Bogotá 111221, Colombia. Electronic address: [email protected].
² Research Institute, Fundación Universitaria de Ciencias de la Salud, Bogotá 111221, Colombia; Department of Pathology, Fundación Universitaria de Ciencias de la Salud, Bogotá 111221, Colombia.
³ Research Institute, Fundación Universitaria de Ciencias de la Salud, Bogotá 111221, Colombia.

No abstract available

Publication types

Comment

MeSH terms

COVID-19*
Colchicine
Humans
SARS-CoV-2
Treatment Outcome

Substances

Colchicine